Author

Stephanie Plaßmann

ORCID 0009-0003-8456-6772Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:CITE-seq· 1 Approach:experimental assay· 1 Assay:scRNA-seq· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Anja DrögeiD· 2 shared Dominik BentsiD· 2 shared Kristin GennermanniD· 2 shared Nadine GenzeliD· 2 shared Sigrid Schaper· 2 shared Steffen HennigiD· 2 shared Volker LennerziD· 2 shared Volkhard SeitziD· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Anja DrögeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 24, 2026

Tumor-versus-non-tumor T cell enrichment supported by single-cell and spatial phenotyping enables antigen-agnostic prioritization of candidate tumor-reactive TCRs

Volkhard Seitz, Jannik Franzen, Kristin Gennermann…·Sefer Elezkurtaj

The paper identifies tumor-reactive TCRs using T/N ratios and validates them with single-cell and spatial data, showing their tumor association and effector phenotype.

DOI 10.64898/2026.09.18.750832

humanscRNA-seq

𝕏 PostBluesky

ImmunologyFrontiers in ImmunologyPeer-reviewedMar 17, 2025

T-cell receptors identified by a personalized antigen-agnostic screening approach target shared neoantigen KRAS Q61H

Volker Lennerz, Christoph Doppler, Martina Fatho…·Steffen Hennig

The paper identifies T-cell receptors targeting KRAS Q61H neoantigen in NSCLC patients using antigen-agnostic screening and demonstrates their reactivity and potential for adoptive cell therapy.

8 citations

humanCITE-seq

𝕏 PostBluesky